openPR Logo
Press release

Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opportunities and Forecast 2022-2027

08-22-2022 03:18 PM CET | Health & Medicine

Press release from: IMARC Group

Antifibrinolytic Drugs Market Size, Share, Trends, Global

The latest research study "Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/antifibrinolytic-drugs-market/requestsample

Industry Definition and Application:

Antifibrinolytic drugs are medicines used for promoting the formation of blood clots to prevent fibrinolysis or blockage in arteries and veins. They restrict the breakdown of fibrin to treat hemorrhage, coagulation disorders, and vascular tumors. These drugs are also used to control the bleeding during or after intrusive surgeries and manage mucosal bleeding in the nose, gastrointestinal (GI) tract, oropharynx, and uterine-vaginal linings. As a result, antifibrinolytic drugs are widely adopted across clinics, hospitals, and ambulatory surgical centers.

Global Antifibrinolytic Drugs Market Trends and Drivers:

The market is primarily driven by the rising incidence of road accidents, trauma, and several bleeding disorders. In addition, the increasing product adoption to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neuro surgeries represents another major growth-inducing factor. Moreover, the market is further propelled by the growing awareness among the masses regarding the available treatment options for genetic angioedema and hemophilia.

Besides this, various technological advancements and the increasing utilization of antifibrinolytic therapy to reduce transfusion in orthopedic patients are accelerating the drug adoption rate. Moreover, other factors, including the rising geriatric population, the introduction of innovative drug variants with improved effectiveness and bio-absorbability, and significant improvements in the healthcare infrastructure, are anticipated to propel market growth in the coming years.

Global Antifibrinolytic Drugs Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/antifibrinolytic-drugs-market

The report has segmented the market on the basis of region, indication, form and end user.

Breakup by Indication:
• Gynecology
• Hereditary Angioedema
• Fibrinolytic Response Testing
• Surgeries
• Others

Breakup by Form:
• Oral
• Injectable

Breakup by End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Trauma Centers
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Related Reports by IMARC Group:

Electric Vehicle Range Extender Market Report: https://www.imarcgroup.com/electric-vehicle-range-extender-market

Premise Cable Market Report: https://www.imarcgroup.com/premise-cable-market

Collaborative Robot Market Report: https://www.imarcgroup.com/collaborative-robot-market

Plastic Contract Manufacturing Market Report: https://www.imarcgroup.com/plastic-contract-manufacturing-market

Coffee Pods and Capsules Market Report: https://www.imarcgroup.com/coffee-pods-capsules-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opportunities and Forecast 2022-2027 here

News-ID: 2712007 • Views:

More Releases from IMARC Group

Global Plywood Market Size, Share, Industry Overview, Latest Insights and Forecast 2025-2033
Global Plywood Market Size, Share, Industry Overview, Latest Insights and Foreca …
IMARC Group, a leading market research company, has recently releases a report titled "Plywood Market Size, Share, Trends and Forecast by Residential and Commercial Application, New Construction and Replacement Sector, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global plywood market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Plywood
Mattress Market Size, Share, Industry Trends, Growth and Forecast 2025-2033
Mattress Market Size, Share, Industry Trends, Growth and Forecast 2025-2033
IMARC Group, a leading market research company, has recently releases a report titled "Mattress Market Report by Product (Innerspring Mattresses, Memory Foam Mattresses, Latex Mattresses, and Others), Distribution Channel (Online Distribution, Offline Distribution), Size (Twin or Single Size, Twin XL Size, Full or Double Size, Queen Size, King Size Mattress, and Others), Application (Domestic, Commercial), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global
Global Apixaban Prices Q2 2025: Chart, Analysis & Forecast
Global Apixaban Prices Q2 2025: Chart, Analysis & Forecast
North America Apixaban Prices Movement Q2: Apixaban Prices in USA: In Q2 2025, apixaban prices in the USA reached 44,617 USD/MT in June. Prices rose steadily, supported by consistent demand for cardiovascular therapies, higher API production and compliance costs, and stable healthcare utilization. Generics moderated volatility, yet firm supply chains and sustained consumption maintained a controlled, input cost-driven price increase. Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample Note: The analysis can be tailored to align
Global Nitrobenzene Prices Q1 2025: Chart, Analysis & Forecast
Global Nitrobenzene Prices Q1 2025: Chart, Analysis & Forecast
North America Nitrobenzene Prices Movement Q1: Nitrobenzene Prices in USA: In Q1 2025, nitrobenzene prices in the USA reached 1,450 USD/MT in March. Firm demand from aniline and MDI sectors supported prices, while harsh winter weather disrupted production and logistics. Tight benzene availability, caused by refinery fluctuations, added upstream cost pressures, straining supply chains and shaping overall market dynamics. Get the Real-Time Prices Analysis: https://www.imarcgroup.com/nitrobenzene-pricing-report/requestsample Note: The analysis can be tailored to align with

All 5 Releases


More Releases for Antifibrinolytic

Increasing Road Accidents Fuel Growth in Antifibrinolytic Drug Market: A Signifi …
The Antifibrinolytic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Antifibrinolytic Drugs Market Size and Projected Growth Rate? Over the past few years, there has been robust growth in the size of the antifibrinolytic drugs market. The growth from $16.82 billion in
Antifibrinolytic Drugs Market Expected to Reach $19,333 Million by 2026 | Top Re …
According to a new report published by Allied Market Research, titled, "Antifibrinolytic Drugs Market by Indication and End User: Global opportunity analysis and industry forecast, 2019-2026," the global antifibrinolytic drugs market size is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value. Antifibrinolytics are one of the most commonly used drugs to prevent fibrinolysis by blocking the activation of plasminogen
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What market dynamics are playing a key role in accelerating the growth of the antifibrinolytic drugs market? The escalating rate of road mishaps projects an upward trajectory for the antifibrinolytic drugs market. Causes for this surge in road accidents range from smartphone usage, excessive speed, driving while intoxicated, and poor vehicle upkeep. Antifibrinolytic medications have a critical role in managing hemorrhage in victims of road crashes by consolidating blood clots, curtailing
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What Are the Market Size and Growth Forecast for the Antifibrinolytic Drugs Market? In the past few years, there has been a significant expansion in the size of the antifibrinolytic drugs market. The market, which was valued at $16.82 billion in 2024, is projected to rise to $17.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The surge in this market over the historical period is largely
Antifibrinolytic Drugs Market Opportunities and Forecasts, 2017 – 2025
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis. Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein.
Antifibrinolytic Drugs Market Foreseen to Grow Exponentially Over 2017 - 2025 : …
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis. Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein.